AML with the mutated NPM1 gene is a distinct subtype according the 2016 World Health Organization (WHO) classification, due to its specific mutational profile, immunophenotype, clinical behavior and mutual exclusiveness to other recurring genomic alterations [87]. Here, NPM1 is linked to acute myeloid leukemia.